• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞缺氧诱导波形蛋白过表达促进肾癌细胞血管生成拟态。

Vimentin Overexpressions Induced by Cell Hypoxia Promote Vasculogenic Mimicry by Renal Cell Carcinoma Cells.

机构信息

Department of Urology, The Second Affiliated Hospital of Shantou University Medical College, China.

Department of Urology, The First Affiliated Hospital of Shantou University Medical College, China.

出版信息

Biomed Res Int. 2019 Jul 21;2019:7259691. doi: 10.1155/2019/7259691. eCollection 2019.

DOI:10.1155/2019/7259691
PMID:31428643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6679895/
Abstract

Vasculogenic mimicry (VM), the novel approach for tumor cells to obtain blood supply, was reported to be involved in antiangiogenic resistance and poor prognosis in renal cell carcinoma (RCC). However, the molecular mechanisms underlying VM formed by RCC cells are still not clearly depicted. In the present study, we found that OS-RC-2 acquired the VM forming ability accompanied with the increased expressions of Vimentin and AXL and decreased expression of E-Cadherin by CoCl treatment. Downregulation of Vimentin by siRNA severely impaired the capability of OS-RC-2 and 786-O to form VM structures induced by cell hypoxia in vitro. Moreover, knockdown of Vimentin inhibited cell migration and invasion, which could be prompted by hypoxia induction in RCC cells. In our clear cell RCC tissues, we found that VM was positively correlated with Vimentin overexpression and both predicted poor prognosis. In conclusion, Vimentin plays an important role in hypoxia induced VM formation of RCC cells and targeted Vimentin might be beneficial for RCC therapy.

摘要

血管生成拟态(VM)是肿瘤细胞获得血液供应的新途径,据报道,它与肾细胞癌(RCC)中的抗血管生成耐药和预后不良有关。然而,RCC 细胞形成的 VM 的分子机制尚不清楚。在本研究中,我们发现 CoCl 处理后 OS-RC-2 获得了形成 VM 的能力,同时 Vimentin 和 AXL 的表达增加,E-Cadherin 的表达减少。通过 siRNA 下调 Vimentin 可严重损害 OS-RC-2 和 786-O 在体外细胞缺氧诱导下形成 VM 结构的能力。此外,Vimentin 的敲低抑制了 RCC 细胞缺氧诱导的迁移和侵袭能力。在我们的透明细胞 RCC 组织中,我们发现 VM 与 Vimentin 过表达呈正相关,两者均预示着预后不良。总之,Vimentin 在缺氧诱导的 RCC 细胞 VM 形成中起重要作用,靶向 Vimentin 可能有益于 RCC 的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/3cd6d22c0c64/BMRI2019-7259691.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/c69849e32e52/BMRI2019-7259691.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/e81c9a87ec8a/BMRI2019-7259691.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/ce29615d152d/BMRI2019-7259691.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/b99e3a4201bd/BMRI2019-7259691.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/99fa7e87bf7c/BMRI2019-7259691.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/3cd6d22c0c64/BMRI2019-7259691.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/c69849e32e52/BMRI2019-7259691.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/e81c9a87ec8a/BMRI2019-7259691.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/ce29615d152d/BMRI2019-7259691.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/b99e3a4201bd/BMRI2019-7259691.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/99fa7e87bf7c/BMRI2019-7259691.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/213e/6679895/3cd6d22c0c64/BMRI2019-7259691.006.jpg

相似文献

1
Vimentin Overexpressions Induced by Cell Hypoxia Promote Vasculogenic Mimicry by Renal Cell Carcinoma Cells.细胞缺氧诱导波形蛋白过表达促进肾癌细胞血管生成拟态。
Biomed Res Int. 2019 Jul 21;2019:7259691. doi: 10.1155/2019/7259691. eCollection 2019.
2
Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.透明细胞肾癌细胞的血管生成拟态需要基质金属蛋白酶-9。
Urol Oncol. 2015 Apr;33(4):168.e9-16. doi: 10.1016/j.urolonc.2014.12.007. Epub 2015 Jan 21.
3
Curcumin Inhibits Vasculogenic Mimicry Regulating ETS-1 in Renal Cell Carcinoma.姜黄素抑制血管生成拟态调控肾细胞癌中的 ETS-1。
Curr Cancer Drug Targets. 2024;24(10):1031-1046. doi: 10.2174/0115680096277126240102060617.
4
LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma.长链非编码 RNA-SERB 促进肾细胞癌中的血管生成拟态(VM)形成和肿瘤转移。
J Biol Chem. 2024 May;300(5):107297. doi: 10.1016/j.jbc.2024.107297. Epub 2024 Apr 18.
5
Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.尿激酶型纤溶酶原激活物受体阳性(uPAR+)亚群在大细胞肺癌中促成血管生成拟态和转移。
Exp Mol Pathol. 2015 Apr;98(2):136-44. doi: 10.1016/j.yexmp.2015.02.001. Epub 2015 Feb 4.
6
RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.RUNX3 抑制人肾细胞癌的迁移、侵袭和血管生成。
PLoS One. 2013;8(2):e56241. doi: 10.1371/journal.pone.0056241. Epub 2013 Feb 14.
7
Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.下调肌球蛋白结合蛋白 F 可通过降低 MMP-2 并诱导间质-上皮转化来抑制黑色素瘤的血管生成拟态。
J Cell Mol Med. 2018 Mar;22(3):1743-1754. doi: 10.1111/jcmm.13455. Epub 2017 Nov 22.
8
TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.TR4 核受体通过改变 miR490-3p/波形蛋白信号促进肾透明细胞癌(ccRCC)血管生成拟态(VM)形成和转移。
Oncogene. 2018 Nov;37(44):5901-5912. doi: 10.1038/s41388-018-0269-1. Epub 2018 Jul 4.
9
MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.MTHFD2过表达预示肾细胞癌预后不良,并与细胞增殖以及波形蛋白调节的迁移和侵袭相关。
Cell Physiol Biochem. 2018;51(2):991-1000. doi: 10.1159/000495402. Epub 2018 Nov 22.
10
Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.缺氧通过诱导卵巢癌中的上皮-间充质转化促进血管生成拟态形成。
Gynecol Oncol. 2014 Jun;133(3):575-83. doi: 10.1016/j.ygyno.2014.02.034. Epub 2014 Feb 28.

引用本文的文献

1
Curcumin Inhibits Vasculogenic Mimicry Regulating ETS-1 in Renal Cell Carcinoma.姜黄素抑制血管生成拟态调控肾细胞癌中的 ETS-1。
Curr Cancer Drug Targets. 2024;24(10):1031-1046. doi: 10.2174/0115680096277126240102060617.
2
Therapeutic potential of vasculogenic mimicry in urological tumors.血管生成拟态在泌尿系统肿瘤中的治疗潜力
Front Oncol. 2023 Sep 21;13:1202656. doi: 10.3389/fonc.2023.1202656. eCollection 2023.
3
Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells.

本文引用的文献

1
Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.下调肌球蛋白结合蛋白 F 可通过降低 MMP-2 并诱导间质-上皮转化来抑制黑色素瘤的血管生成拟态。
J Cell Mol Med. 2018 Mar;22(3):1743-1754. doi: 10.1111/jcmm.13455. Epub 2017 Nov 22.
2
Targeted therapies for renal cell carcinoma.肾细胞癌的靶向治疗。
Nat Rev Nephrol. 2017 Aug;13(8):496-511. doi: 10.1038/nrneph.2017.82. Epub 2017 Jul 10.
3
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
滋养层细胞侵袭与分化中的自噬过程:与癌细胞的异同
Front Oncol. 2021 Apr 15;11:637594. doi: 10.3389/fonc.2021.637594. eCollection 2021.
4
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.缺氧肿瘤微环境中的血管生成拟态机制。
Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1.
5
Oncometabolite L-2-hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma.代谢物 L-2-羟基戊二酸通过 PHLDB2 在肾细胞癌中直接诱导血管生成拟态。
Int J Cancer. 2021 Apr 1;148(7):1743-1755. doi: 10.1002/ijc.33435. Epub 2021 Jan 15.
在缺氧肿瘤微环境中,缺氧诱导因子-1α(HIF-1α)通过上调赖氨酰氧化酶样蛋白2(LOXL2)促进肝细胞癌中的血管生成拟态形成。
J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.
4
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
5
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
6
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.依维莫司影响对舒尼替尼耐药的肾癌中的血管生成拟态。
Oncotarget. 2016 Jun 21;7(25):38467-86. doi: 10.18632/oncotarget.9542.
7
Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.波形蛋白过表达和碳酸酐酶IX低表达是非转移性透明细胞肾癌复发、特异性生存和总生存的独立预测因素:一项验证性研究
World J Urol. 2017 Jan;35(1):81-87. doi: 10.1007/s00345-016-1854-y. Epub 2016 May 20.
8
The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.肿瘤治疗中血管生成拟态相关的缺氧信号通路。
Biomed Pharmacother. 2016 May;80:127-135. doi: 10.1016/j.biopha.2016.03.010. Epub 2016 Mar 21.
9
Hypoxic control of metastasis.转移的缺氧控制
Science. 2016 Apr 8;352(6282):175-80. doi: 10.1126/science.aaf4405. Epub 2016 Apr 7.
10
The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.血管生成拟态与上皮-间质转化之间的关系。
J Cell Mol Med. 2016 Sep;20(9):1761-9. doi: 10.1111/jcmm.12851. Epub 2016 Mar 29.